A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...

Explore the rising prevalence of weight-loss drugs in India, their impact on health and wellness, and the critical balance ...

For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

In patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced ...

Can Novo Nordisk get its comeback going in 2026? Let's discuss two things that could materialize for the company next year ...

New findings from a major trial offer a clearer, more nuanced view of how GLP-1 medications may influence the course of ...

The list of benefits for Novo Nordisk's semaglutide keeps getting longer. Now, it seems the GLP-1 agonist could help patients with heart failure, adding to earlier studies showing it can treat ...

Up to 50 cats are expected to participate in the trial, with their weight and health metrics monitored at three and six ...

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Elevating Aesthetic Dermatology in Rockville with Innovative Med Spa Services Under CEO Janine Shore’ Rockville, United States – December 11, 2025 / Shore Dermatology / Shore Dermatology, a ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...